CIMT 2018 Annual Meeting

May 15-17, 2018
Mainz, Germany

Viola Marschall, Ph.D., Senior Scientist Assay Development
Matthias Schröder, Ph.D., Senior Scientist Assay Development
Julian Sefrin, Ph.D., Senior Scientist Immunology

Poster Presentations:
Anticancer immunity mediated by the novel hexavalent human GITR agonist HERA-GITRL is conveyed by activating T cells without affecting Treg cells
(Dr. Marschall)
HERA-LIGHT, a novel hexavalent HVEM agonist promoting T cell activation and expansion (Dr. Sefrin)


2018 ASCO Annual Meeting

June 1-5, 2018
Chicago, USA

Thomas Hoeger, Ph.D., Chief Executive Officer
Harald Fricke, M.D., Chief Medical Officer
Juergen Gamer, Ph.D., VP Business Development